➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Johnson and Johnson
McKinsey
Moodys
Express Scripts

Last Updated: August 13, 2020

DrugPatentWatch Database Preview

METRONIDAZOLE IN PLASTIC CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Metronidazole In Plastic Container patents expire, and what generic alternatives are available?

Metronidazole In Plastic Container is a drug marketed by Baxter Hlthcare Corp, Hospira, Inforlife, and Mylan Labs Ltd. and is included in four NDAs.

The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the metronidazole profile page.

US ANDA Litigation and Generic Entry Outlook for Metronidazole In Plastic Container

A generic version of METRONIDAZOLE IN PLASTIC CONTAINER was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.

  Start Trial

Drug patent expirations by year for METRONIDAZOLE IN PLASTIC CONTAINER
Recent Clinical Trials for METRONIDAZOLE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Auckland, New ZealandPhase 2/Phase 3
New York Medical CollegePhase 4
KRKAN/A

See all METRONIDAZOLE IN PLASTIC CONTAINER clinical trials

Pharmacology for METRONIDAZOLE IN PLASTIC CONTAINER

US Patents and Regulatory Information for METRONIDAZOLE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 078084-001 Mar 31, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 205531-001 May 9, 2017 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 018890-002 Nov 18, 1983 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Inforlife METRONIDAZOLE IN PLASTIC CONTAINER metronidazole INJECTABLE;INJECTION 206191-001 Feb 25, 2019 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Colorcon
AstraZeneca
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.